Effect of sleeve gastrectomy on plasma growth differentiation factor-15 (GDF15) in human

Am J Surg. 2020 Sep;220(3):725-730. doi: 10.1016/j.amjsurg.2020.01.041. Epub 2020 Jan 28.

Abstract

Background: Sleeve gastrostomy (SG) induces significant weight loss primarily as a result of increased satiety and reduced food intake. Growth differentiation factor-15 (GDF15) is a satiety hormone which induces a dramatic reduction of food intake and body weight.

Objective: To assess the effect of sleeve gastrectomy on plasma GDF 15 level and the association with the weight loss and diabetes control after SG.

Method: We assessed plasma GDF15 level in 21 patients (15 with obesity and 6 with obesity and diabetes) before and then at 1, 3 and 12 months after SG.

Results: GDF15 was significantly increased at 1 month after SG compared to before surgery level (301.9 ± 135.2 pg/ml vs 215.1 ± 119.9 pg/ml, respectively p<0.05) and increased even further at 3 months (338.86 ± 131.14 pg/ml, p<0.01) and remain elevated at 12 months (329.39 ± 152.1 pg/ml p<0.05) after SG. At 3 months after surgery, the increased GDF15 level was correlated with the magnitude of BMI loss (r2 = 0.204, p<0.05).

Conclusion: SG induces a significant increase in GDF15 level which is correlated with the magnitude of BMI loss.

Keywords: Bariatric surgery; Growth differential factor 15; Obesity; Sleeve gastrectomy; Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Gastrectomy / methods*
  • Growth Differentiation Factor 15 / blood*
  • Humans
  • Male
  • Middle Aged
  • Time Factors
  • Weight Loss*
  • Young Adult

Substances

  • GDF15 protein, human
  • Growth Differentiation Factor 15